Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ENROLLING BY INVITATION
NCT06743243
PHASE4

Effect of Tegoprazan for Elective Surgery Patients Under General Anesthesia

Sponsor: Seok Kyeong Oh

View on ClinicalTrials.gov

Summary

The aim of this study is to compare gastric pH right after endotracheal intubation for general anesthesia in patients pretreated with tegoprazan, famotidine, or placebo.

Key Details

Gender

All

Age Range

20 Years - 69 Years

Study Type

INTERVENTIONAL

Enrollment

174

Start Date

2025-07-23

Completion Date

2026-12-30

Last Updated

2025-09-05

Healthy Volunteers

No

Interventions

DRUG

Tegoprazan

Tegoprazan OD tab. 50 mg PO + Saline 20ml IV, one hour before general anesthesia.

DRUG

Famotidine

Famotidine 20mg/10ml+saline 10ml IV + Tegoprazan OD tab. 50 mg placebo PO, one hour before general anesthesia.

DRUG

Placebo

Tegoprazan OD tab. 50 mg placebo PO + Saline 20ml IV, one hour before general anesthesia.

Locations (1)

Korea University Medical Center, Guro Hospital

Seoul, South Korea